Presentation of multivariate data for clinical use: The Framingham Study risk score functions

被引:1300
作者
Sullivan, LM
Massaro, JM
D'Agostmo, RB
机构
[1] Boston Univ, Stat & Consulting Unit, Dept Math & Stat, Boston, MA 02215 USA
[2] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
关键词
regression models; points system; multivariable analysis; risk scores; prediction functions;
D O I
10.1002/sim.1742
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Framingham Heart Study has been a leader in the development and dissemination of multivariable statistical models to estimate the risk of coronary heart disease. These models quantify the impact of measurable and modifiable risk factors on the development of coronary heart disease and can be used to generate estimates of risk of coronary heart disease over a predetermined period, for example the next 10 years. We developed a system, which we call a points system, for making these complex statistical models useful to practitioners. The system is easy to use, it does not require a calculator or computer and it simplifies the estimation of risk based on complex statistical models. This system represents an effort to make available a tool for clinicians to aid in their decision-making process regarding treatment and to assist them in motivating patients toward healthy behaviours. The system is also readily available to patients who can easily estimate their own coronary heart disease risk and monitor this risk over time. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:1631 / 1660
页数:30
相关论文
共 14 条
  • [1] AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS
    ANDERSON, KM
    WILSON, PWF
    ODELL, PM
    KANNEL, WB
    [J]. CIRCULATION, 1991, 83 (01) : 356 - 362
  • [2] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.1997.00440420033005, DOI 10.1001/ARCHINTE.1997.00440420033005]
  • [3] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [4] CORNFIELD J, 1960, B INT STATIST INST, V38, P97
  • [5] Primary and subsequent coronary risk appraisal: New results from The Framingham Study
    D'Agostino, RB
    Russell, MW
    Huse, DM
    Ellison, RC
    Silbershatz, H
    Wilson, PWF
    Hartz, SC
    [J]. AMERICAN HEART JOURNAL, 2000, 139 (02) : 272 - 281
  • [6] STROKE RISK PROFILE - ADJUSTMENT FOR ANTIHYPERTENSIVE MEDICATION - THE FRAMINGHAM-STUDY
    DAGOSTINO, RB
    WOLF, PA
    BELANGER, AJ
    KANNEL, WB
    [J]. STROKE, 1994, 25 (01) : 40 - 43
  • [7] DAGOSTINO RB, 2001, J ANTI-AGING MED, V296, P180
  • [8] GENERAL CARDIOVASCULAR RISK PROFILE - FRAMINGHAM STUDY
    KANNEL, WB
    MCGEE, D
    GORDON, T
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1976, 38 (01) : 46 - 51
  • [9] Profile for estimating risk of heart failure
    Kannell, WB
    D'Agostino, RB
    Silbershatz, H
    Belanger, AJ
    Wilson, PWF
    Levy, D
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (11) : 1197 - 1204
  • [10] Murabito JM, 1997, CIRCULATION, V96, P44